Energenx Medical

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Energenx Medical - overview

Established

2021

Location

Shanghai, -, China

Primary Industry

Healthcare

About

Founded in 2021 and based in Shanghai, China, Energenx Medical is a provider of respiratory and oncology interventional technology, focusing on high-incidence diseases such as chronic bronchitis, chronic obstructive pulmonary disease, and lung cancer. It utilizes pulsed electric field (PEF) platform technology to advance clinical treatment. In September 2025, Galvanize Therapeutics, Inc. , a portfolio company of Apple Tree Partners, Fidelity Investments, Gilmartin Capital, Intuitive Surgical, Inc.


, to fully acquire Energenx Medical. Energenx Medical has developed a pulsed electric field (PEF) product portfolio encompassing solutions for chronic obstructive pulmonary disease (COPD) and interventional oncology, and established an independent intellectual property protection system.   The company generates revenue through researching and providing solutions for chronic obstructive pulmonary disease (COPD) and interventional oncology.


Primary Industry

Healthcare

Sub Industries

Biotechnology, Healthcare

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Energenx Medical - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onAnnouncedEnergenx Medical-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.